Chris Bolten is a globally recognized IP attorney focusing on MedTech and technology fields. He represents over 50 MedTech companies and VCs in the medical device and digital health industries–including those utilizing artificial intelligence (AI)–across the United States, Europe, and Israel. Chris has handled over 100 IP diligences for premiere venture capital firms and for MedTech companies. From 2022-2024, he served as IP counsel for the company or investors in MedTech acquisitions valued at over $32 Billion. Having litigated dozens of patent cases in federal court across the United States for MedTech companies and other household name companies, Chris builds litigation-ready IP to facilitate investment, acquisition, and enforcement.
Chris handles matters involving medical technologies like structural heart devices, stents, shunts, prosthetic heart valves, robotics, neuromodulation devices, ablation devices, diagnostics, drug delivery devices, and software including machine learning and AI. He also works with telecommunications technologies such as networking and internet systems. His experience includes IP portfolio strategy, patent prosecution, FTO opinions, and litigation.